Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.30 |
---|---|
High | 3.42 |
Low | 3.10 |
Bid | 3.10 |
Offer | 3.20 |
Previous close | 3.19 |
Average volume | 9.65k |
---|---|
Shares outstanding | 35.62m |
Free float | 33.16m |
P/E (TTM) | -- |
Market cap | 113.89m CAD |
EPS (TTM) | -1.37 CAD |
Data delayed at least 15 minutes, as of Oct 09 2024 21:00 BST.
More ▼
Press releases
- Eupraxia Pharmaceuticals Strengthens Senior Management Team
- Eupraxia Pharmaceuticals to Present at 20th ISDE World Congress for Esophageal Diseases
- Eupraxia Pharmaceuticals Announces Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
- Eupraxia Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results
- Eupraxia Pharmaceuticals Announces New C$12 Million Convertible Debt Facility
More ▼